TOT BIOPHARM Competitors and Similar CompaniesClear all

TOT BIOPHARM's competitors and similar companies include Sunesis Pharmaceuticals, Halozyme Therapeutics, Navigen and Exonate.

	TOT BIOPHARM TOT BIOPHARM is a biopharmaceutical company that develops oncology drugs and therapies.	Sunesis Pharmaceuticals Sunesis Pharmaceuticals is focused on the R&D of oncology therapeutics for the treatment of solid and hematologic cancers.	Halozyme Therapeutics Halozyme Therapeutics is a biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment.	Navigen Navigen is a pharmaceutical discovery and development company.	Exonate Exonate is a biopharmaceutical company with drug discovery programs in ophthalmology, oncology and pain.
Founding Date	Founding Date 2009	Founding Date 1987	Founding Date 1998	Founding Date 2006	Founding Date 2013
Type	Type Public	Type Subsidiary	Type Public	Type Private	Type Private
Tags	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma
Locations	Locations Suzhou Shi, CN HQ	Locations South San Francisco, US HQ	Locations San Diego, US HQ	Locations Salt Lake City, US HQ	Locations Duxford, GB HQ
Employees	Employees 611	Employees 42	Employees 373157% increase	Employees 13	Employees 15
Financial
Net income	Net income N/A	Net income ($114.8m) (FY, 2021)	Net income $316.9m (FY, 2025)	Net income N/A	Net income N/A
Funding
Latest funding round	Latest funding round N/A	Latest funding round N/A	Latest funding round N/A	Latest funding round $ 1.7m (about 9 years ago)	Latest funding round $ 1.9m (over 7 years ago)
Total funding raised	Total funding raised $ 108m	Total funding raised $ 171.7m	Total funding raised $ 171.9m	Total funding raised $ 1.7m	Total funding raised $ 11.8m